<?xml version="1.0" encoding="UTF-8"?>
<p>Another approach is to use hyper-immune intravenous anti-CHIKV immunoglobulins to prevent CHIKV infection in neonates, who often develop very severe forms of the disease. Indeed, after a conclusive study in neonate mice [
 <xref rid="B252-microorganisms-07-00133" ref-type="bibr">252</xref>], a Phase II trial is currently in progress [
 <xref rid="B253-microorganisms-07-00133" ref-type="bibr">253</xref>].
</p>
